MINERALS TECHNOLOGIES INC
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
Note 1. Summary of Significant Accounting Policies
Minerals Technologies Inc. (the “Company”) is a leading, technology-driven specialty minerals company that develops, produces, and markets a broad range of mineral and mineral-based products, related systems and services. The Company serves globally a wide range of consumer and industrial markets, including household and personal care, paper and packaging, food and pharmaceutical, automotive, construction, steel and foundry, environmental, and infrastructure.
Basis of Presentation
The accompanying consolidated financial statements include the accounts of the Company, its wholly and majority-owned subsidiaries, as well as variable interest entities for which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The Company employs accounting policies that are in accordance with U.S. generally accepted accounting principles and require management to make estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reported period. Significant estimates include those related to valuation of long-lived assets, goodwill and other intangible assets, certain pension plan assumptions, valuation of deferred income tax assets, and litigation and environmental liabilities. Actual results could differ from those estimates.
Cash Equivalents and Short-term Investments
The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Short-term investments consist of financial instruments, mainly bank deposits, with original maturities beyond three months, but less than twelve months. Short-term investments amounted to $4.0 million and $4.3 million at December 31, 2024 and 2023, respectively. There wereno unrealized holding gains or losses on the short-term bank investments held at December 31, 2024.
Trade Accounts Receivable
Trade accounts receivables are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company determines the allowance based on historical write-off experience and specific allowances for bankrupt customers. The Company also analyzes the collection history and financial condition of its other customers, considering current industry conditions and determines whether an allowance needs to be established. The Company reviews its allowance for doubtful accounts monthly. Past due balances over 90 days based on payment terms are reviewed individually for collectability. Allowance for doubtful accounts was $17.1 million and $20.3 million at December 31, 2024 and 2023, respectively. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers.
Allowance for Credit Losses
The allowance for credit losses (ACL) is management's estimate of the current expected credit losses at the balance sheet date. Our credit exposure includes an unfunded loan commitment. For this exposure, we recognized an ACL associated with the unfunded amount, which is reported as a liability in accrued expenses and other current liabilities on our consolidated balance sheet.
Inventories
Inventories are valued at the lower of cost or market. Cost is determined by the first-in, first-out (FIFO) method.
Additionally, items such as idle facility expense, freight handling costs, and re-handling costs are recognized as current period charges. The allocation of fixed production overheads to the costs of conversion are based upon the normal capacity of the production facility. Fixed overhead costs associated with idle capacity are expensed as incurred.
Property, Plant and Equipment
Property, plant and equipment are recorded at cost. Significant improvements are capitalized, while maintenance and repair expenditures are charged to operations as incurred. The Company capitalizes interest cost as a component of construction in progress. The straight-line method of depreciation is used for substantially all the assets for financial reporting purposes, except for mining related equipment which uses units-of-production method. The annual rates of depreciation are 3% -6.67% for buildings,6.67% -12.5% for machinery and equipment,8% -12.5% for furniture and fixtures and 12.5% -25% for computer equipment and software-related assets. The estimated useful lives of our PCC production facilities and machinery and equipment pertaining to our natural stone mining and processing plants and our chemical plants are 15 years.
Property, plant and equipment are depreciated over their useful lives. Useful lives are based on management’s estimates of the period that the assets can generate revenue, which does not necessarily coincide with the remaining term of a customer’s contractual obligation to purchase products made using those assets. The Company’s sales of PCC are predominantly pursuant to long-term evergreen contracts, initiallyten years in length, with paper mills at which the Company operates satellite PCC plants. The terms of many of these agreements have been extended, often in connection with an expansion of the satellite PCC plant. Failure of a PCC customer to renew an agreement or continue to purchase PCC from a Company facility could result in an impairment of assets charge or accelerated depreciation at such facility.
Depletion of mineral reserves is determined on a unit-of-extraction basis for financial reporting purposes, based upon proven and probable reserves, and generally on a percentage depletion basis for tax purposes.
Stripping Costs Incurred During Production
Stripping costs are those costs incurred for the removal of waste materials for the purpose of accessing ore body that will be produced commercially. Stripping costs incurred during the production phase of a mine are variable costs that are included in the costs of inventory produced during the period that the stripping costs are incurred.
Accounting for the Impairment of Long-Lived Assets
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, the Company estimates the undiscounted future cash flows (excluding interest), resulting from the use of the asset and its ultimate disposition. If the sum of the undiscounted cash flows (excluding interest) is less than the carrying value, the Company recognizes an impairment loss, measured as the amount by which the carrying value exceeds the fair value of the asset, determined principally using discounted cash flows.
Goodwill and Other Intangible Assets
Goodwill represents the excess of purchase price and related costs over the value assigned to the net tangible and identifiable intangible assets of businesses acquired. Goodwill is not amortized, but instead assessed for impairment. Intangible assets with estimable useful lives are amortized on a straight-line basis over their respective estimated lives to the estimated residual values and reviewed for impairment.
The Company performs a qualitative assessment for each of its reporting units to determine if the two-step process for impairment testing is required. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company would then evaluate the recoverability of goodwill using a two-step impairment test approach at the reporting unit level. In the first step, the fair value for the reporting unit is compared to its book value including goodwill. In the case that the fair value of the reporting unit is less than book value, a second step is performed which compares the fair value of the reporting unit’s goodwill to the book value of the goodwill. The fair value for the goodwill is determined based on the difference between the fair values of the reporting unit and the net fair values of the identifiable assets and liabilities of such reporting unit. If the fair value of the goodwill is less than the book value, the difference is recognized as impairment.
In addition to the assessment of goodwill impairment, the Company also reviews its other identifiable intangibles for impairment. Each year, the Company reviews whether events or changes in circumstances could indicate that a long-lived asset’s carrying amount may not be recoverable. Should such events occur, the value of intangibles not recoverable would be recognized as impairment.
Investment in Joint Ventures
The Company uses the equity method of accounting to record the results of its investments in companies in which it has significant influence but does not control; and cost method of accounting in companies in which it cannot exercise significant control. The Company records the equity in earnings of its investments in joint ventures on a one-month lag. At December 31, 2024 and 2023, the book value of the Company’s equity method investments was $23.4 million and $20.0 million.
Accounting for Asset Retirement Obligations
The Company provides for obligations associated with the retirement of long-lived assets and the associated asset retirement costs. The fair value of a liability for an asset retirement obligation is recognized in the period in which it is incurred if a reasonable estimate of fair value can be made. The associated asset retirement costs are capitalized as part of the carrying amount of the long-lived asset. The Company also provides for legal obligations to perform asset retirement activities where timing or methods of settlement are conditional on future events.
The Company also records liabilities related to land reclamation as a part of the asset retirement obligations. The Company mines land for various minerals using a surface-mining process that requires the removal of overburden. In many instances, the Company is obligated to restore the land upon completion of the mining activity. As the overburden is removed, the Company recognizes this liability for land reclamation based on the estimated fair value of the obligation. The obligation is adjusted to reflect the passage of time and changes in estimated future cash outflows.
Fair Value of Financial Instruments
The recorded amounts of cash and cash equivalents, receivables, short-term borrowings, accounts payable, accrued interest, and variable-rate long-term debt approximate fair value because of the short maturity of those instruments or the variable nature of underlying interest rates. Short-term investments are recorded at cost, which approximates fair market value.
Derivative Financial Instruments
The Company records derivative financial instruments which are used to hedge certain foreign exchange risk at fair value on the balance sheet. See Note 12 for a full description of the Company’s hedging activities and related accounting policies.
Revenue Recognition
Revenue is recognized at the point in time when the customer obtains control of the promised goods or services in an amount that reflects the consideration we expect to receive in exchange for those goods or services. The Company’s revenues are primarily derived from the sale of products. Our primary performance obligation is satisfied upon shipment or delivery to our customer based on written sales terms, which is also when control is transferred. Revenues from sales of equipment are recorded upon completion of installation and transfer of control to the customer. Revenue where our performance obligations are satisfied in phases is recognized over time using certain input measures based on the measurement of the value transferred to the customer, including milestones achieved. Revenues from services are recorded when the services are performed.
In most of our PCC contracts, the price per ton is based upon the total number of tons sold to the customer during the year. Under those contracts, the price billed to the customer for shipments during the year is based on periodic estimates of the total annual volume that will be sold to the customer. Revenues are adjusted at the end of each year to reflect the actual volume sold. There wereno significant revenue adjustments in the fourth quarter of 2024 and 2023, respectively. We have consignment arrangements with certain customers in our Engineered Solutions segment. Revenues for these transactions are recorded when the consigned products are consumed by the customer.
Foreign Currency
The assets and liabilities of the Company’s international subsidiaries are translated into U.S. dollars using exchange rates at the respective balance sheet date. The resulting translation adjustments are recorded in accumulated other comprehensive income (loss) in shareholders’ equity. Income statement items are generally translated at monthly average exchange rates prevailing during the period. International subsidiaries operating in highly inflationary economies translate non-monetary assets at historical rates, while net monetary assets are translated at current rates, with the resulting translation adjustments included in net income. At December 31, 2024, the Company had no international subsidiaries operating in highly inflationary economies, with the exception of its subsidiaries in Turkey.
Income Taxes
Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
The Company operates in multiple taxing jurisdictions, both within the U.S. and outside the U.S. In certain situations, a taxing authority may challenge positions that the Company has adopted in its income tax filings. The Company regularly assesses its tax position for such transactions and includes reserves for those differences in position. The reserves are utilized or reversed once the statute of limitations has expired or the matter is otherwise resolved.
The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and are often ambiguous. As such, we are required to make many subjective assumptions and judgments regarding our income tax exposures. Interpretations of and guidance surrounding income tax laws and regulations change over time. As such, changes in our subjective assumptions and judgments can materially affect amounts recognized in the consolidated balance sheets and statements of operations. The Company’s accounting policy is to recognize interest and penalties as part of its provision for income taxes. See Note 8 for additional details on our uncertain tax positions.
The accompanying financial statements do not include a provision for foreign withholding taxes on international subsidiaries’ unremitted earnings, which are expected to be permanently reinvested overseas.
Research and Development
Research and development costs are expensed as incurred.
Accounting for Stock-Based Compensation
The Company recognizes compensation expense for share-based awards based upon the grant date fair value over the vesting period.
Pension and Post-retirement Benefits
The Company has defined benefit pension plans covering the majority of its eligible employees. The benefits are generally based on years of service and an employee’s modified career earnings.
The Company also provides post-retirement healthcare benefits for the majority of its retirees and employees in the United States. The Company measures the costs of its obligation based on its best estimate. The net periodic costs are recognized as employees render the services necessary to earn the post-retirement benefits.
Environmental
Expenditures that relate to current operations are expensed or capitalized as appropriate. Expenditures that relate to an existing condition caused by past operations and which do not contribute to current or future revenue generation are expensed. Liabilities are recorded when it is probable the Company will be obligated to pay amounts for environmental site evaluation, remediation or related costs, and such amounts can be reasonably estimated.
Earnings Per Share
Basic earnings per share have been computed based upon the weighted average number of common shares outstanding during the period.
Diluted earnings per share have been computed based upon the weighted average number of common shares outstanding during the period assuming the issuance of common shares for all potentially dilutive common shares outstanding.
Subsequent Events
The Company has evaluated for subsequent events through the date of issuance of its financial statements.
Recently Issued Accounting Standards
Changes to accounting principles generally accepted in the United States of America (U.S. GAAP) are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates (ASUs) to the FASB’s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position and results of operations.
Adoption of Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires entities to report incremental information about significant segment expenses included in a segment’s profit or loss measure, as well as the name and title of the chief operating decision maker. The guidance also requires interim disclosures related to reportable segment profit or loss and assets that had previously only been disclosed annually. The new standard is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2023. The Company adopted this guidance on January 1, 2024 and updated the disclosures contained in Note 21. This guidance did not impact the Company's consolidated financial statements.
Income Taxes (Topic 740): Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, that requires entities to disclose additional information about federal, state, and foreign income taxes primarily related to the income tax rate reconciliation and income taxes paid. The new standard also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. The new standard is effective for interim and annual periods beginning on or after December 15, 2024. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements, but will result in disaggregation of the Company's tax footnote.
Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, that requires entities to disclose additional information in the notes to the financial statements about prescribed categories underlying any relevant income statement expense caption. The new standard is effective for annual periods beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.
Note 2. Leases
The Company determines if an arrangement is a lease at inception. The Company has operating leases for premises, equipment, rail cars and automobiles. Our leases have remaining lease terms of 1 year to 50 years, some of which may include options to extend the leases further. The Company considers these options in determining the lease term used to establish the right-of-use assets and lease liabilities. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based upon the information available at commencement date, or as of implementation of ASC 842, in determining the present value of lease payments.
Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense for these leases on a straight-line basis over the lease term. Certain lease agreements contain both lease and non-lease components. We account for lease components together with non-lease components.
Operating lease cost was $17.3 million, $16.8 million and $15.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. The components of lease costs are as follows:
| December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Operating lease cost | $17.3 | $16.7 | $15.6 |
| Short-term lease cost | — | 0.1 | 0.1 |
| Total | $17.3 | $16.8 | $15.7 |
Supplemental cash flow information and non-cash activity related to our leases are as follows:
| (millions of dollars) | December 31, 2024 |
|---|---|
| Operating cash flows information: | |
| Cash paid for amounts included in the measurement of lease liabilities | $18.2 |
| Non-cash activity: | |
| Right-of-use assets obtained in the exchange for operating lease liabilities | $17.6 |
Weighted average remaining lease term and weighted average discount rates related to the Company’s leases were as follows:
| Weighted-average remaining operating lease term (in years) | 5.30 |
|---|---|
| Weighted-average operating leases discount rate | 6.0% |
The following table summarizes the Company’s outstanding lease assets and liabilities and their classification on the Consolidated Balance Sheet:
| December 31, | |||
|---|---|---|---|
| (millions of dollars) | Balance Sheet Classification | 2024 | 2023 |
| Right-of-use-asset | Other assets and deferred charges | $46.9 | $44.1 |
| Lease liability - current | Other current liabilities | 14.5 | 13.5 |
| Lease liability - non-current | Other non-current liabilities | 38.7 | 37.9 |
Future minimum lease payments under the Company’s leases as of December 31, 2024 were as follows:
| (millions of dollars) | December 31, 2024 |
|---|---|
| 2025 | $17.2 |
| 2026 | 14.7 |
| 2027 | 10.8 |
| 2028 | 8.4 |
| 2029 | 3.1 |
| Thereafter | 8.1 |
| Total future minimum lease payments | 62.3 |
| Less imputed interest | (9.1) |
| Total | $53.2 |
Note 3. Revenue from Contracts with Customers
The Company's revenues are primarily derived from the sale of products in product lines within our Consumer & Specialties and Engineered Solutions businesses.
Our primary performance obligation (the sale of products) is satisfied upon shipment or delivery to our customers based on written sales terms, which is also when control is transferred. In most of our contracts in our Specialty Additives product line, which is in our Consumer & Specialties segment, the price per ton is based upon the total number of tons sold to the customer during the year. Under these contracts, the price billed to the customer for shipments during the year is based on periodic estimates of the total annual volume that will be sold to such customer. Revenues are adjusted at the end of each year to reflect the actual volume sold.
Revenue from sales of equipment, primarily in our High-Temperature Technologies product line within our Engineered Solutions segment, is recorded upon completion of installation and control is transferred to the customer. Revenue from services is recorded when the services have been performed. Included within our High-Temperature Technologies product line are certain consignment arrangements with certain customers in our Engineered Solutions segment. Revenues for these transactions are recorded when the consigned products are consumed by the customer and control is transferred.
Revenue where our performance obligations are satisfied in phases is recognized over time using certain input measures based on the measurement of the value transferred to the customer, including milestones achieved.
The following table disaggregates our revenue by major source (product line) for the years ended December 31, 2024, 2023 and 2022:
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Net Sales | |||
| Household & Personal Care | $530.0 | $517.6 | $476.2 |
| Specialty Additives | 610.2 | 642.6 | 648.4 |
| Consumer & Specialties Segment | 1,140.2 | 1,160.2 | 1,124.6 |
| High-Temperature Technologies | 713.2 | 720.9 | 702.5 |
| Environmental & Infrastructure | 265.1 | 288.8 | 298.4 |
| Engineered Solutions Segment | 978.3 | 1,009.7 | 1,000.9 |
| Total | $2,118.5 | $2,169.9 | $2,125.5 |
Note 4. Acquisitions
Concept Pet Heimtierprodukte GmbH
On April 29, 2022, the Company completed the acquisition of Concept Pet Heimtierprodukte GmbH (“Concept Pet”), a European supplier of pet litter products. The purchase of Concept Pet supports the expansion of our European pet care business, as well as providing additional mineral reserves. The purchase price was $28.0 million and the acquisition was financed through cash on hand. The fair value of the total consideration transferred, net of cash acquired, was $22.4 million. In the second quarter of 2023, an additional $1.8 million of hold back consideration was paid. In the second quarter of 2024, an additional $4.0 million was paid representing the final hold back consideration. The results of Concept Pet are included within our Household & Personal Care product line in our Consumer & Specialties segment. The acquisition has been accounted for using the acquisition method of accounting, which requires, among other things, that we recognize the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The Company recorded goodwill of $9.3 million and intangible assets of $4.3 million relating to this acquisition.
The Company incurredno acquisition related transaction and integration costs during 2024 and recorded $0.3 million and $5.1 million of acquisition-related costs during 2023 and 2022, respectively, which are reflected within the acquisition-related expenses line of the Consolidated Statements of Income.
Note 5. Restructuring and Other Items, net
In the third quarter of 2023, the Company recorded a $71.7 million non-cash impairment of long-lived assets charge related to its subsidiaries BMI Oldco Inc. (f/k/a Barretts Minerals Inc.) ("Oldco") and Barretts Ventures Texas LLC ("BVT") within the Consumer & Specialties segment. This impairment was triggered by increased claims and continued increases in legal costs, which led to the voluntary filing for relief under Chapter 11 of the U.S. Bankruptcy Code to address and comprehensively resolve Oldco’s liabilities associated with the talc claims. See Note 17 for further information.
In the second quarter of 2023, the Company initiated a restructuring and cost savings program to further streamline our cost structure as a result of organizational efficiencies gained through our 2023 resegmentation. As a result, the Company recorded a charge of $6.6 million for restructuring and other charges related to severance and other costs. In the third quarter of 2023, an incremental charge of $0.3 million was recorded relating to this program.
The following table outlines the amount of restructuring charges recorded within the Consolidated Statements of Income and the segments they relate to:
| Restructuring and Other Items, net | Year Ended December 31, | ||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Asset Write-Downs | |||
| Consumer & Specialties | $— | $71.7 | $— |
| Total asset write-down charges | $— | $71.7 | $— |
| Severance and other employee costs | |||
| Consumer & Specialties | $— | $0.9 | $— |
| Engineered Solutions | — | 3.2 | — |
| Corporate | — | 2.8 | — |
| Total severance and other employee costs | $— | $6.9 | $— |
| Total restructuring and other items, net | $— | $78.6 | $— |
At December 31, 2024 and 2023, the Company had $2.4 million and $3.8 million, respectively, included within other current liabilities within our Consolidated Balance Sheets for cash expenditures needed to satisfy remaining obligations under these reorganization initiatives. The Company expects to pay these remaining restructuring obligations by the end of the second quarter of 2025.
The following table is a reconciliation of our restructuring liability balance as of December 31, 2024 and 2023:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Restructuring liability, beginning of period | $3.8 | $— |
| Additional provisions | — | 6.9 |
| Cash payments | (1.4) | (2.8) |
| Other | — | (0.3) |
| Restructuring liability, end of period | $2.4 | $3.8 |
Note 6. Stock-Based Compensation
The Company’s 2015 Stock Award and Incentive Plan provides for grants of incentive and non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, stock awards and performance unit awards (the 2015 Stock Award and Incentive Plan, as amended, referred to herein as the “Plan” and together with its predecessor for awards granted prior to May 2015, the 2001 Stock Award and Incentive Plan, as amended and restated, the “Plans”). At the Company's 2024 Annual Meeting of Stockholders, the Company's stockholders ratified the adoption of an amendment and restatement of the Plan, which increased the number of shares available for issuance pursuant to the Plan by 889,000 shares and removed certain individual award limits in light of recent tax law changes. The Plans are administered by the Compensation Committee of the Board of Directors. Stock options granted under the Plans generally have aten year term. The exercise price for stock options are at prices at or above the fair market value of the common stock on the date of the grant, and each award of stock options will vest ratably over a specified period, generally three years.
Stock-based compensation expense is recognized in the consolidated financial statements for stock options based on the grant date fair value.
Net income for the years ended 2024, 2023 and 2022 include $5.4 million, $5.2 million and $4.8 million pre-tax compensation costs, respectively, related to stock option expense as a component of marketing and administrative expenses. All stock option expense is recognized in the consolidated statements of operations. The related tax benefit included in the statement of income on the non-qualified stock options was $1.4 million, $1.4 million and $1.3 million for 2024, 2023 and 2022, respectively.
Stock Options
The fair value of options granted is estimated on the date of grant using the Black-Scholes valuation model. Compensation expense is recognized only for those options expected to vest, with forfeitures estimated at the date of grant based on the Company’s historical experience and future expectations. The forfeiture rate assumption used for the periods ended December 31, 2024, 2023 and 2022 was 7.69%,7.91% and 8.09%, respectively.
The weighted average grant date fair value for stock options granted during the years ended December 31, 2024, 2023 and 2022 was $25.33, $25.11 and $24.26, respectively. The weighted average grant date fair value for stock options vested during 2024, 2023 and 2022 was $23.75, $21.56 and $19.82, respectively. The total intrinsic value of stock options exercised during the years ended December 31, 2024, 2023 and 2022 was $7.0 million, $1.0 million and $2.0 million, respectively.
The fair value for stock awards was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted average assumptions for the years ended December 31, 2024, 2023 and 2022:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected life (in years) | 6.5 | 6.4 | 6.7 |
| Interest rate | 4.06% | 3.51% | 1.70% |
| Volatility | 31.93% | 32.05% | 31.92% |
| Expected dividend yield | 0.61% | 0.30% | 0.28% |
The expected term of the options represents the estimated period of time until exercised and is based on historical experience of similar awards, based upon contractual terms, vesting schedules, and expectations of future employee behavior. The expected stock-price volatility is based upon the historical and implied volatility of the Company’s stock. The interest rate is based upon the implied yield on U.S. Treasury bills with an equivalent remaining term. Estimated dividend yield is based upon historical dividends paid by the Company.
The following table summarizes stock option activity for the year ended December 31, 2024:
| Awards | Weighted Average Exercise Price per Share | Weighted Average Remaining Contractual Life (Years) | Aggregate Intrinsic Value (Millions) | |
|---|---|---|---|---|
| Awards outstanding at December 31, 2023 | 1,514,462 | $63.15 | ||
| Granted | 196,471 | 66.72 | ||
| Exercised | (279,810) | 55.85 | ||
| Canceled | (5,487) | 66.76 | ||
| Expired | — | — | ||
| Awards outstanding at December 31, 2024 | 1,425,636 | $65.06 | 5.88 | $16.1 |
| Awards exercisable at December 31, 2024 | 997,406 | $64.24 | 4.82 | $12.1 |
The aggregate intrinsic value above is calculated before applicable income taxes, based on the Company’s closing stock price of $76.21 as of the last business day of the period ended December 31, 2024 had all options been exercised on that date. The weighted average intrinsic value of the options exercised during 2024, 2023 and 2022 was $24.85, $7.78 and $16.34 per share, respectively. As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested stock options was approximately $5.1 million, which is expected to be recognized over a weighted average period of approximately three years.
The Company issues new shares of common stock upon the exercise of stock options.
Non-vested stock option activity for the year ended December 31, 2024 is as follows:
| Awards | Weighted Average Grant Date Fair Value per Share | |
|---|---|---|
| Nonvested awards outstanding at December 31, 2023 | 460,141 | $67.18 |
| Granted | 196,471 | 66.72 |
| Vested | (222,895) | 67.21 |
| Canceled | (5,487) | 66.76 |
| Nonvested awards outstanding at December 31, 2024 | 428,230 | $66.96 |
Deferred Restricted Stock Units
The Company has granted key employees units consisting of rights to receive shares of the Company’s common stock pursuant to the Plans. The rights will be deferred for a specified number of years of service, subject to restrictions on transfer and other conditions. Compensation expense for these shares is recognized over the vesting period. The Company granted units consisting of rights to receive 103,169 shares,102,843 shares and 98,464 shares during the periods ended December 31, 2024, 2023 and 2022, respectively. The fair value was determined based on the market value of unrestricted shares. As of December 31, 2024, there was unrecognized stock-based compensation related to deferred restricted stock units of $7.2 million, which will be recognized over approximately the next three years. The compensation expense amortized with respect to all units was approximately $6.5 million, $6.0 million and $5.7 million for the periods ended December 31, 2024, 2023 and 2022, respectively. In addition, the Company recorded reversals of $2.8 million, $2.7 million and $2.7 million for periods ended December 31, 2024, 2023 and 2022, respectively, related mostly to the conversion of units for tax withholding purposes. Such costs and reversals are included in marketing and administrative expenses.
The following table summarizes the deferred restricted stock unit activity for the Plan:
| Awards | Weighted Average Grant Date Fair Value per Share | |
|---|---|---|
| Unvested balance at December 31, 2023 | 187,350 | $67.15 |
| Granted | 103,169 | 66.79 |
| Vested | (47,876) | 67.19 |
| Canceled | (43,849) | 67.21 |
| Unvested balance at December 31, 2024 | 198,794 | $66.94 |
Note 7. Earnings Per Share (EPS)
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions, except per share data) | 2024 | 2023 | 2022 |
| Net income attributable to MTI | $167.1 | $84.1 | $122.2 |
| Weighted average shares outstanding | 32.1 | 32.5 | 32.7 |
| Dilutive effect of stock options and deferred restricted stock units | 0.2 | 0.1 | 0.1 |
| Weighted average shares outstanding, adjusted | 32.3 | 32.6 | 32.8 |
| Basic earnings per share attributable to MTI | $5.21 | $2.59 | $3.74 |
| Diluted earnings per share attributable to MTI | $5.17 | $2.58 | $3.73 |
Of the options outstanding of 1,425,636,1,514,462 and 1,363,418 for the years ended December 31, 2024, 2023 and 2022, respectively, options to purchase 194,412 shares,917,177 shares and 754,867 shares of common stock for the years ended December 31, 2024, 2023 and 2022, respectively, were not included in the computation of diluted earnings per share because they were anti-dilutive, as the exercise prices of the options were greater than the average market price of the common shares.
Note 8. Income Taxes
Income (loss) from operations before provision for taxes by domestic and foreign source is as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Income (loss) from operations before income taxes and income from affiliates and joint ventures: | |||
| Domestic | $40.7 | $(38.9) | $39.3 |
| Foreign | 182.9 | 146.6 | 117.4 |
| $223.6 | $107.7 | $156.7 | |
The provision (benefit) for taxes on income consists of the following:
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Domestic | |||
| Taxes currently payable | |||
| Federal | $20.0 | $9.5 | $16.3 |
| State and local | 2.8 | 6.7 | 3.3 |
| Deferred income taxes | (12.3) | (31.5) | (16.0) |
| Domestic tax provision (benefit) | 10.5 | (15.3) | 3.6 |
| Foreign | |||
| Taxes currently payable | 44.2 | 42.2 | 29.8 |
| Deferred income taxes | 4.7 | (3.2) | (1.3) |
| Foreign tax provision | 48.9 | 39.0 | 28.5 |
| Total tax provision | $59.4 | $23.7 | $32.1 |
The provision (benefit) for taxes on income shown in the previous table is classified based on the location of the taxing authority, regardless of the location in which the taxable income is generated.
The major elements contributing to the difference between the U.S. federal statutory tax rate and the consolidated effective tax rate are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| U.S. statutory rate | 21.0% | 21.0% | 21.0% |
| Depletion | (4.4)% | (10.3)% | (6.1)% |
| Difference between tax provided on foreign earnings and the U.S. statutory rate | 4.7% | 7.7% | 2.4% |
| Global Intangible Low-Tax Income (GILTI) | 0.1% | 1.0% | 2.3% |
| Foreign Derived Intangible Income | (1.0)% | (2.5)% | — |
| State and local taxes, net of federal tax benefit | 1.4% | (0.1)% | (0.4)% |
| Tax credits | (0.7)% | (0.6)% | (0.4)% |
| Bankruptcy Funding | 3.1% | — | — |
| Impact of uncertain tax positions | (0.3)% | 0.2% | (1.3)% |
| Impact of officer’s non-deductible compensation | 1.1% | 1.9% | 1.3% |
| Foreign Withholding Tax | 0.8% | 2.0% | 1.2% |
| Other | 0.8% | 1.7% | 0.5% |
| Consolidated effective tax rate | 26.6% | 22.0% | 20.5% |
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Deferred tax assets attributable to: | ||
| Accrued liabilities | $31.4 | $26.8 |
| Net operating loss carry forwards | 23.2 | 32.8 |
| Pension and post-retirement benefits costs | 2.9 | 16.0 |
| Interest | 16.2 | 9.1 |
| Research and development capitalization | 11.0 | 7.7 |
| Valuation allowance | (20.6) | (25.2) |
| Other | 13.3 | 21.3 |
| Total deferred tax assets | 77.4 | 88.5 |
| Deferred tax liabilities attributable to: | ||
| Plant and equipment, principally due to differences in depreciation | 138.0 | 146.0 |
| Intangible assets | 49.5 | 53.6 |
| Other | 5.6 | 12.2 |
| Total deferred tax liabilities | 193.1 | 211.8 |
| Net deferred tax liability | $(115.7) | $(123.3) |
Net deferred tax assets and net deferred tax liabilities are classified as follows:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Net deferred tax asset, long-term | $14.8 | $16.0 |
| Net deferred tax liability, long-term | 130.5 | 139.3 |
| Net deferred tax liability, long-term | $(115.7) | $(123.3) |
The Company has $23.2 million of deferred tax assets arising from tax loss carry forwards which will be realized through future operations. Carry forwards of approximately $14.2 million expire over the next 20 years, and $9.0 million can be utilized over an indefinite period.
On December 31, 2024, the Company had $1.9 million of total unrecognized tax benefits. Included in this amount were a total of $1.3 million of unrecognized income tax benefits that, if recognized, would affect the Company’s effective tax rate. While it is expected that the amount of unrecognized tax benefits will change in the next 12 months, we do not expect the change to have a significant impact on the results of operations or the financial position of the Company.
The following table summarizes the activity related to our unrecognized tax benefits:
| (millions of dollars) | 2024 | 2023 |
|---|---|---|
| Balance at beginning of the year | $2.8 | $2.6 |
| Increases related to current year tax positions | 0.5 | 0.5 |
| Decreases related to audit settlements and statute expirations | (1.4) | (0.3) |
| Balance at the end of the year | $1.9 | $2.8 |
The Company’s accounting policy is to recognize interest and penalties accrued, relating to unrecognized income tax benefits as part of its provision for income taxes. The Company recorded a net reversal of $0.1 million in interest and penalties during 2024 and had a total accrued balance on December 31, 2024 of $0.4 million. The Company believes that its accrued liabilities are sufficient to cover its U.S. and foreign tax contingencies.
The Company operates in multiple taxing jurisdictions, both within and outside the U.S. In certain situations, a taxing authority may challenge positions that the Company has adopted in its income tax filings. The Company, with a few exceptions (none of which are material), is no longer subject to U.S. federal, state, local, and international income tax examinations by tax authorities for years prior to 2017.
Net cash paid for income taxes were $70.8 million, $53.8 million and $44.0 million for the years ended December 31, 2024, 2023 and 2022, respectively.
The Company had approximately $497.7 million of foreign subsidiaries’ undistributed earnings as of December 31, 2024. We intend to continue to permanently reinvest these earnings overseas for the foreseeable future and while U.S. federal tax expense has been recognized as a result of recent U.S. tax code changes, no deferred tax liabilities with respect to foreign withholding taxes or state taxes have been recognized.
In December 2021, the Organization for Economic Co-operation and Development (“OECD”) released the Pillar Two Model Rules which aim to reform international corporate taxation rules, including the implementation of a global minimum tax rate. The Company began implementation of the Pillar Two Model Rules in the first quarter of 2024. The Company continues to assess the effect of the Pillar 2 Model Rules in all jurisdictions and does not expect that Pillar 2 will have a material impact on its consolidated financial statements.
Note 9. Inventories
The following is a summary of inventories by major category:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Raw materials | $167.7 | $144.3 |
| Work-in-process | 12.3 | 11.7 |
| Finished goods | 106.7 | 113.5 |
| Packaging and supplies | 55.4 | 55.9 |
| Total inventories | $342.1 | $325.4 |
Note 10. Property, Plant and Equipment
The major categories of property, plant and equipment and accumulated depreciation and depletion are presented below:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Mineral rights and reserves | $560.0 | $552.6 |
| Land | 43.0 | 44.5 |
| Buildings | 202.0 | 207.3 |
| Machinery and equipment | 1,236.4 | 1,201.1 |
| Furniture and fixtures and other | 144.5 | 140.0 |
| Construction in progress | 50.7 | 44.6 |
| 2,236.6 | 2,190.1 | |
| Less: accumulated depreciation and depletion | (1,246.9) | (1,203.3) |
| Property, plant and equipment, net | $989.7 | $986.8 |
In the fourth quarter of 2024, the Company recorded a $12.3 million net gain on sale of assets for a facility within the Engineered Solutions segment.
In the third quarter of 2023, the Company recorded a $71.7 million non-cash impairment of long-lived assets charge related to its subsidiaries Oldco and BVT within the Consumer & Specialties segment. See Note 17 for further information.
Depreciation and depletion expense for the years ended December 31, 2024, 2023 and 2022 was $79.5 million, $79.4 million and $76.3 million, respectively.
Note 11. Goodwill and Other Intangible Assets
Goodwill and other intangible assets with indefinite lives are not amortized, but instead are assessed for impairment, at least annually. The carrying amount of goodwill was $913.8 million and $913.6 million as of December 31, 2024 and December 31, 2023, respectively. The net change in goodwill since December 31, 2024 was attributable to the effects of foreign exchange.
The balance of goodwill by reporting unit and the activity occurring in the past two fiscal years is as follows:
| (millions of dollars) | Consumer & Specialties | Engineered Solutions | Consolidated |
|---|---|---|---|
| Balance at December 31, 2022 | $346.4 | $568.4 | $914.8 |
| Change in goodwill relating to: | |||
| Foreign exchange translation | (1.2) | — | (1.2) |
| Total Changes | $(1.2) | $— | $(1.2) |
| Balance at December 31, 2023 | $345.2 | $568.4 | $913.6 |
| Change in goodwill relating to: | |||
| Foreign exchange translation | 0.5 | (0.3) | 0.2 |
| Total Changes | $0.5 | $(0.3) | $0.2 |
| Balance at December 31, 2024 | $345.7 | $568.1 | $913.8 |
Acquired intangible assets subject to amortization as of December 31, 2024 and December 31, 2023 were as follows:
| December 31, 2024 · December 31, 2023 | |||||
|---|---|---|---|---|---|
| (in millions of dollars) · (in millions of dollars) | |||||
| Weighted Average Useful Life (Years) | Gross Carrying Amount | Accumulated Amortization | Gross Carrying Amount | Accumulated Amortization | |
| Tradenames | 34 | $221.5 | $63.0 | $221.5 | $59.1 |
| Technology | 13 | 18.8 | 15.1 | 18.8 | 14.2 |
| Patents and trademarks | 19 | 6.4 | 6.4 | 6.4 | 6.4 |
| Customer relationships | 21 | 77.5 | 21.6 | 79.0 | 15.0 |
| 29 | $324.2 | $106.1 | $325.7 | $94.7 | |
The weighted average amortization period of the acquired intangible assets subject to amortization is approximately 29 years. Amortization expense was approximately $12.1 million, $12.7 million and $12.7 million for the years ended December 31, 2024, 2023 and 2022, respectively and is recorded within the Marketing and administrative expenses line within the Consolidated Statements of Income. The estimated amortization expense is as follows: 2025 - $11.5 million; 2026 -$11.5 million; 2027 - $11.5 million; 2028 -$11.5 million; 2029 - $11.5 million and $160.6 million thereafter.
Note 12. Derivative Financial Instruments and Hedging Activities
As a multinational corporation with operations throughout the world, the Company is exposed to certain market risks. The Company uses a variety of practices to manage these market risks, including, when considered appropriate, derivative financial instruments. The Company’s objective is to offset gains and losses resulting from interest rates and foreign currency exposures with gains and losses on the derivative contracts used to hedge them. The Company uses derivative financial instruments only for risk management and not for trading or speculative purposes.
By using derivative financial instruments to hedge exposures to changes in interest rates and foreign currencies, the Company exposes itself to credit risk and market risk. Credit risk is the risk that the counterparty will fail to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company owes the counterparty, and therefore, it does not face any credit risk. The Company minimizes the credit risk in derivative instruments by entering into transactions with major financial institutions.
Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates, currency exchange rates, or commodity prices. The market risk associated with interest rate and forward exchange contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken.
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the Company records the effective portion of the gain or loss in accumulated other comprehensive income (loss) as a separate component of shareholders’ equity. The Company subsequently reclassifies the effective portion of gain or loss into earnings in the period during which the hedged transaction is recognized in earnings.
The Company utilizes interest rate swaps to limit exposure to market fluctuations on floating-rate debt. In the second quarter of 2023, the Company entered into a floating to fixed interest rate swap for a notional amount of $150 million. The fair value of this swap is an asset of $0.3 million at December 31, 2024 and is recorded in other assets and deferred charges on the Consolidated Balance Sheet. This interest rate swap is designated as a cash flow hedge. As a result, the gains and losses associated with this interest rate swap are recorded in accumulated other comprehensive income (loss).
Other
The Company is exposed to potential gains or losses from foreign currency fluctuations affecting net investments and earnings denominated in foreign currencies. The Company is particularly sensitive to currency exchange rate fluctuations for the following currencies: British pound sterling (GBP), Chinese renminbi (CNY), Euro, Malaysian ringgit (MYR), Polish zloty (PLN), South African Rand (ZAR), Thai baht (THB) and Turkish lira (TRY). When considered appropriate, the Company enters into foreign exchange derivative contracts to mitigate the risk of fluctuations on these exposures. The Company does not designate these contracts for hedge accounting treatment and the changes in fair value of these contracts are recorded in earnings. The Company recorded losses of $0.1 million, $0.1 million and $0.8 million in other non-operating income (deductions), net within the Consolidated Statements of Income for the years ended 2024, 2023 and 2022 respectively. There wereno open contracts at December 31, 2024 and December 31, 2023.
Note 13. Fair Value of Financial Instruments
Fair value is an exchange price that would be received for an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability. The Company follows a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs about which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Assets and liabilities measured at fair value are based on one or more of three valuation techniques. The three valuation techniques are as follows:
| ● | Market approach – prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. |
| ● | Cost approach – amount that would be required to replace the service capacity of an asset or replacement cost. |
| ● | Income approach – techniques to convert future amounts to a single present amount based on market expectations, including present value techniques, option-pricing and other models. |
The Company primarily applies the income approach for foreign exchange derivatives for recurring fair value measurements and attempts to utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.
The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities accounted for at fair value on a recurring basis at the end of each of the past two years. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.
| (millions of dollars) | Fair Value Measurements Using | |||
|---|---|---|---|---|
| Asset / (Liability) Balance at | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |
| Description | December 31, 2024 | (Level 1) | (Level 2) | (Level 3) |
| Deferred compensation plan assets | $13.6 | $— | $13.6 | $— |
| Supplementary pension plan assets | 19.4 | — | 19.4 | — |
| Interest rate swap | 0.3 | — | 0.3 | — |
| Fair Value Measurements Using | ||||
|---|---|---|---|---|
| Asset / (Liability) Balance at | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |
| Description | December 31, 2023 | (Level 1) | (Level 2) | (Level 3) |
| Deferred compensation plan assets | $13.7 | $— | $13.7 | $— |
| Supplementary pension plan assets | 15.5 | — | 15.5 | — |
| Interest rate swap | (0.1) | — | (0.1) | — |
The fair value of foreign exchange contracts is determined based on inputs that are readily available in public markets or can be derived from information available in publicly quoted markets and are categorized as Level 2. Deferred compensation and supplementary pension plan assets related to the Company’s 2014 acquisition of AMCOL International Corporation are valued using quoted prices for similar assets in active markets.
The Company does not have any financial assets or liabilities measured at fair value on a recurring basis categorized as Level 3, except for pension assets discussed in Note 16, and there wereno transfers in or out of Level 3 during the year ended December 31, 2024 and 2023. There were also no changes to the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis.
Note 14. Financial Instruments and Concentrations of Credit Risk
The following methods and assumptions were used to estimate the fair value of each class of financial instrument:
Cash and cash equivalents, short-term investments, accounts receivable and payable: The carrying amounts approximate fair value because of the short maturities of these instruments.
Short-term debt and other liabilities: The carrying amounts of short-term debt and other liabilities approximate fair value because of the short maturities of these instruments.
Long-term debt: The fair value of the long-term debt of the Company is estimated based on the quoted market prices for that debt or similar debt and approximates the carrying amount.
Forward exchange contracts: The fair value of forward exchange contracts (used for hedging purposes) is based on information derived from active markets. If appropriate, the Company would enter into forward exchange contracts to mitigate the impact of foreign exchange rate movements on the Company’s operating results. It does not engage in speculation. Such foreign exchange contracts would offset losses and gains on the assets, liabilities and transactions being hedged.
Credit risk: The Company provides credit to customers in the ordinary course of business. The Company’s customer base is diverse and includes customers located throughout the world. Credit risk results from the possibility that a loss may occur from the failure of another party to perform according to the terms of the contracts. The Company regularly monitors its credit risk exposures and takes steps to mitigate the likelihood of these exposures resulting in an actual loss. In the second quarter of 2024, the Company entered into a Debtor-in-Possession Credit Agreement with Oldco and recorded a provision for credit losses of $30.0 million for the maximum principal amount under such Credit Agreement. See Note 17 for further information. The Company’s extension of credit is based on an evaluation of the customer’s financial condition and collateral is generally not required.
The Company’s bad debt expense for the years ended December 31, 2024, 2023 and 2022 was $1.4 million, $2.8 million and $4.1 million, respectively.
Note 15. Long-Term Debt and Commitments
The following is a summary of long-term debt:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Secured Credit Agreement: | ||
| Term Loan due 2031, net of unamortized deferred financing cost and original issue discount of $7.3 million and $— million | $567.7 | $— |
| Previous Secured Credit Agreement: | ||
| Term Loan due 2027, net of unamortized deferred financing cost of $— million and $2.4 million | — | 530.4 |
| Senior Notes: | ||
| 5.00% due 2028, net of unamortized deferred financing costs of $3.2 million and $3.9 million | 396.8 | 396.1 |
| Other debt | 1.6 | 2.6 |
| Total | $966.1 | $929.1 |
| Less: Current maturities | 6.5 | 18.0 |
| Long-term debt | $959.6 | $911.1 |
On November 26, 2024, the Company, entered into a Refinancing Facility Agreement and Incremental Facility Amendment (the “Amendment”) to amend the previous credit agreement (the "Previous Credit Agreement"; the previous credit agreement, as amended by the Amendment, being the "Amended Credit Agreement").
The Amendment provides for, among other things, a new senior secured revolving credit facility with aggregate commitments of $400 million (the “Revolving Facility”), a portion of which may be used for the issuance of letters of credit and swingline loans, and a new senior secured term loan facility with aggregate commitments of $575 million (the “Term Loan Facility” and, together with the Revolving Facility, the "Senior Secured Credit Facilities"). The Revolving Facility and the Term Loan Facility replace the facilities under the Previous Credit Agreement, which provided for, among other things, a $550 million senior secured term loan facility and a $300 million senior secured revolving credit facility. The maturity date for loans and commitments under the Revolving Facility is November 26, 2029, and the maturity date for loans under the Term Loan Facility is November 26, 2031; provided that the maturity dates of the Revolving Facility and the Term Loan Facility will be adjusted to the date that is 91 days prior to the stated maturity date of the Company’s 5.0% Senior Notes due 2028 (the “Notes”) unless, prior to the date that is 91 days prior to the stated maturity date of the Notes, all amounts in excess of $50 million of the Notes have been either (a) refinanced with indebtedness permitted under the Amended Credit Agreement maturing later than 90 days after the scheduled maturity date of the Revolving Facility or of the Term Loan Facility, as applicable, or (b) repaid, discharged or repaid (other than with the proceeds of any indebtedness maturing earlier than 91 days after the scheduled maturity date of the Revolving Facility or of the Term Loan Facility, as applicable). Loans under the Term Loan Facility amortize at a rate equal to 1.00% per annum, payable in equal quarterly installments, and were issued with original issue discount at 99.875% of par.
Loans under the Revolving Facility will bear interest at a rate equal to (a) for loans denominated in U.S. dollars, at the election of the Company, Term SOFR plus an applicable margin equal to 1.375% per annum or a base rate plus an applicable margin equal to 0.375% per annum, (b) for loans denominated in Euros, adjusted EURIBOR plus an applicable margin equal to 1.375% per annum and (c) for loans denominated in Pounds Sterling, SONIA plus an applicable margin equal to 1.375% per annum, subject in each case to (i) an increase of 37.5 basis points in the event that, and for so long as, the Net Leverage Ratio (as defined in the Amended Credit Agreement) is greater than or equal to 3.00 to 1.00 as of the last day of the preceding fiscal quarter, (ii) an increase of 12.5 basis points in the event that, and for so long as, the Net Leverage Ratio is less than 3.00 to 1.00 and greater than or equal to 2.00 to 1.00 as of the last day of the preceding fiscal quarter and (iii) a decrease of 12.5 basis points in the event that, and for so long as, the Net Leverage Ratio is less than 1.00 to 1.00 as of the last day of the preceding fiscal quarter. Loans under the Term Loan Facility will bear interest at a rate equal to, at the election of the Company, Term SOFR plus an applicable margin equal to 2.00% per annum or a base rate plus an applicable margin equal to 1.00% per annum. The Company will pay certain fees under the Amended Credit Agreement, including (a) a commitment fee of 0.175% per annum on the undrawn portion of the Revolving Facility (subject to a step-ups to 0.300% and 0.250% and a step-down to 0.150% at the same levels described above), (b) a fronting fee of 0.125% per annum on the average daily undrawn amount of, plus unreimbursed amounts in respect of disbursements under, letters of credit issued under the Revolving Facility and (c) customary annual administration fees. The obligations of the Company under the Senior Secured Credit Facilities are unconditionally guaranteed jointly and severally by, subject to certain exceptions, all material domestic subsidiaries of the Company (the “Guarantors”) and secured, subject to certain exceptions, by a security interest in substantially all of the tangible and intangible assets of the Company and the Guarantors.
In thefourth quarter of 2024, the Company recorded $1.8 million in non-cash debt extinguishment expenses related to the refinancing of our credit facilities, which represents the difference between the redemption payment and the carrying value of the debt at the refinancing date. All lenders under the previous facility were repaid in full.
As of December 31, 2024, there were $4.5 million in loans and $9.1 million in letters of credit outstanding under the Revolving Facility.
On June 30, 2020, the Company issued $400 million aggregate principal amount of “Notes”. The Notes were issued pursuant to an indenture, dated as of June 30, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Indenture”). The Notes bear an interest rate of 5.0% per annum payable semi-annually on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes are unconditionally guaranteed on a senior unsecured basis by each of the Company’s existing and future wholly owned domestic restricted subsidiaries that is a borrower under or that guarantees the Company’s obligations under its Senior Secured Credit Facilities or that guarantees the Company’s or any of the Company’s wholly owned domestic subsidiaries’ long-term indebtedness in an aggregate amount in excess of $50 million.
The Company may redeem some or all of the Notes at any time and from time to time at the applicable redemption prices listed in the Indenture, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date.
If the Company experiences a change of control (as defined in the indenture), the Company is required to offer to repurchase the Notes at 101% of the principal amount of such Notes, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.
The Amended Credit Agreement and the Indenture both contain certain customary affirmative and negative covenants that limit or restrict the ability of the Company and its restricted subsidiaries to enter into certain transactions or take certain actions, as well as customary events of default. In addition, the Amended Credit Agreement contains a financial covenant that requires the Company to maintain a maximum Net Leverage Ratio of 4.00 to 1.00 for each four fiscal quarter period (subject to an increase to 5.00 to 1.00 for four quarters in connection with certain significant acquisitions).
The Company has a committed loan facility in Japan. As of December 31, 2024, there was an outstanding balance of $0.9 million on this facility. Principal will be repaid in accordance with the payment schedule ending in 2026. The Company repaid $0.4 million on this loan in 2024.
As part of the Concept Pet acquisition, the Company assumed $1.9 million in long-term debt, recorded at fair value, consisting oftwo terms loans, one that matures in 2025 andone that matures in 2027. Both loans have annual payments and carry a variable interest rate. The Company repaid $0.3 million on these loans during 2024.
As of December 31, 2024, the Company had $24.3 million in uncommitted short-term bank credit lines, $0.6 million of which were in use.
There were $5.1 million and $85.4 million short-term borrowings as of December 31, 2024 and 2023, respectively. The weighted average interest rates on short-term borrowings outstanding was 6.9% for the years ended December 31, 2024 and 2023, respectively.
The aggregate maturities of long-term debt are as follows: $6.5 million in 2025; $6.4 million in 2026; $6.0 million in 2027, $405.8 million in 2028; $5.7 million in 2029 and $546.3 million thereafter.
During 2024, 2023 and 2022, respectively, the Company incurred interest costs of $63.2 million, $64.1 million and $48.6 million, including $1.0 million, $1.0 million and $1.3 million, respectively, which were capitalized. Interest paid approximated the incurred interest cost.
Note 16. Benefit Plans
Pension Plans and Other Postretirement Benefit Plans
The Company and its subsidiaries have pension plans covering the majority of eligible employees on a contributory or non-contributory basis. Benefits under defined benefit plans are generally based on years of service and an employee’s career earnings. Employees generally become fully vested after five years.
The Company also provides postretirement health care and life insurance benefits for the majority of its U.S. retired employees. Employees are generally eligible for benefits upon retirement and completion of a specified number of years of creditable service. The Company does not pre-fund these benefits and has the right to modify or terminate the plan in the future.
The Company’s disclosures for the U.S. plans have been combined with those outside of the U.S. as the international plans do not have significantly different assumptions, and together represent approximately 20% of our total benefit obligation.
The following table sets forth the Company’s pension obligation and funded status at December 31:
| Pension Benefits | Post-Retirement Benefits | |||
|---|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2024 | 2023 |
| Change in benefit obligations: | ||||
| Beginning projected benefit obligation | $368.9 | $348.9 | $2.0 | $1.8 |
| Service cost | 4.2 | 4.5 | — | — |
| Interest cost | 16.0 | 16.0 | 0.1 | 0.1 |
| Actuarial loss (gain) | (25.4) | 11.4 | (0.1) | 0.1 |
| Benefits paid | (18.7) | (15.0) | (0.1) | — |
| Settlements | — | (0.5) | — | — |
| Foreign exchange impact | (3.1) | 3.3 | (0.1) | — |
| Other | 0.4 | 0.3 | — | — |
| Ending projected benefit obligation | 342.3 | 368.9 | 1.8 | 2.0 |
| Change in plan assets: | ||||
| Beginning fair value | 317.4 | 285.4 | — | — |
| Actual return on plan assets | 33.5 | 34.4 | — | — |
| Employer contributions | 11.6 | 9.9 | 0.1 | — |
| Plan participants’ contributions | 0.4 | 0.3 | — | — |
| Benefits paid | (18.7) | (15.0) | (0.1) | — |
| Settlements | — | (0.5) | — | — |
| Foreign exchange impact | (2.9) | 2.9 | — | — |
| Ending fair value | 341.3 | 317.4 | — | — |
| Funded status | $(1.0) | $(51.5) | $(1.8) | $(2.0) |
Amounts recognized in the consolidated balance sheet consist of:
| Pension Benefits | Post-Retirement Benefits | |||
|---|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2024 | 2023 |
| Non-current asset | $19.5 | $— | $— | $— |
| Current liability | (1.6) | (1.8) | (0.1) | (0.1) |
| Non-current liability | (18.9) | (49.7) | (1.7) | (1.9) |
| Net liability recognized | $(1.0) | $(51.5) | $(1.8) | $(2.0) |
The current portion of pension liabilities is included in accrued compensation and related items.
Amounts recognized in accumulated other comprehensive loss, net of related tax effects, consist of:
| Pension Benefits | Post-Retirement Benefits | |||
|---|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2024 | 2023 |
| Net actuarial (gain) loss | $1.2 | $32.0 | $(3.2) | $(3.3) |
| Prior service cost | 0.1 | 0.1 | — | — |
| Amount recognized end of year | $1.3 | $32.1 | $(3.2) | $(3.3) |
The accumulated benefit obligation for all defined benefit pension plans was $327.5 million and $350.3 million at December 31, 2024 and 2023, respectively. The accumulated benefit obligations and projected benefit obligations are in excess of the plan assets for primarily all of the Company’s defined benefit plans.
Changes in the Plan assets and benefit obligations recognized in other comprehensive income:
| Pension Benefits | Post-Retirement Benefits | |||
|---|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2024 | 2023 |
| Current year actuarial gain (loss) | $29.7 | $3.8 | $0.1 | $(0.1) |
| Amortization of actuarial (gain) loss | 1.1 | 2.2 | (0.3) | (0.3) |
| Total recognized in other comprehensive income | $30.8 | $6.0 | $(0.2) | $(0.4) |
The components of net periodic benefit costs are as follows:
| Pension Benefits | Post-Retirement Benefits | |||||
|---|---|---|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 | 2024 | 2023 | 2022 |
| Service cost | $4.2 | $4.5 | $6.6 | $— | $— | $— |
| Interest cost | 16.0 | 16.0 | 11.0 | 0.1 | 0.1 | — |
| Expected return on plan assets | (19.8) | (17.8) | (21.5) | — | — | — |
| Recognized net actuarial (gain) loss | 1.5 | 2.9 | 5.3 | (0.4) | (0.5) | (0.4) |
| Settlement/curtailment (gain) loss | — | 0.1 | 3.5 | — | — | — |
| Net periodic benefit cost | $1.9 | $5.7 | $4.9 | $(0.3) | $(0.4) | $(0.4) |
Unrecognized prior service cost is amortized over the average remaining service period of each active employee.
The Company’s funding policy for U.S. plans generally is to contribute annually into trust funds at a rate that provides for future plan benefits and maintains appropriate funded percentages. Annual contributions to the U.S. qualified plans are at least sufficient to satisfy regulatory funding standards and are not more than the maximum amount deductible for income tax purposes. The funding policies for the international plans conform to local governmental and tax requirements. The plans’ assets are invested primarily in stocks and bonds.
Additional Information
The weighted average assumptions used to determine net periodic benefit cost in the accounting for the pension benefit plans and other benefit plans for the years ended December 31, 2024, 2023 and 2022 are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Discount rate | 5.16% | 4.84% | 4.30% |
| Expected return on plan assets | 6.59% | 6.53% | 6.34% |
| Rate of compensation increase | 2.75% | 2.77% | 2.74% |
| Interest crediting rate | 3.75% | 2.25% | 2.25% |
The weighted average assumptions used to determine benefit obligations for the pension benefit plans and other benefit plans at December 31, 2024, 2023 and 2022 are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Discount rate | 4.75% | 4.63% | 4.84% |
| Rate of compensation increase | 2.75% | 2.76% | 2.76% |
For 2024, 2023 and 2022, the discount rate was based on the FTSE Pension Discount Curve, a yield curve of high quality corporate bonds with cash flows matching our plans’ expected benefit payments. The expected return on plan assets is based on our asset allocation mix and our historical return, taking into account current and expected market conditions. The actual return/(loss) on pension assets was approximately 10% in 2024,11% in 2023 and (22)% in 2022.
The Company maintains a self-funded health insurance plan for its retirees. This plan provided that the maximum health care cost trend rate would be 5%. Effective June 2010, the Company amended its plan to change the eligibility requirement for retirees and revised its plan so that increases in expected health care costs would be borne by the retiree. Effective January 1, 2022, the plan was closed to new retirees.
Plan Assets
The Company’s pension plan weighted average asset allocation percentages at December 31, 2024 and 2023 by asset category are as follows:
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Asset Category | ||
| Equity securities | 55.3% | 51.3% |
| Fixed income securities | 33.1% | 35.3% |
| Real estate | 0.1% | 0.3% |
| Other | 11.5% | 13.1% |
| Total | 100.0% | 100.0% |
The Company’s pension plan fair values at December 31, 2024 and 2023 by asset category are as follows:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Asset Category | ||
| Equity securities | $188.7 | $162.9 |
| Fixed income securities | 112.8 | 112.0 |
| Real estate | 0.3 | 0.8 |
| Other | 39.5 | 41.7 |
| Total | $341.3 | $317.4 |
The following table presents domestic and foreign pension plan assets information at December 31, 2024, 2023 and 2022 (the measurement date of pension plan assets):
| U.S. Plans | International Plans | |||||
|---|---|---|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 | 2024 | 2023 | 2022 |
| Fair value of plan assets | $277.1 | $251.4 | $226.4 | $64.2 | $66.0 | $59.0 |
The following table summarizes our defined benefit pension plan assets measured at fair value as of December 31, 2024:
| Quoted Prices in Active Markets for Identical Assets · Significant Other Observable Inputs · Significant Unobservable Inputs | ||||
|---|---|---|---|---|
| (millions of dollars) | (Level 1) | (Level 2) | (Level 3) | Total |
| Equity securities | ||||
| US equities | $167.2 | $— | $— | $167.2 |
| Non-US equities | 21.5 | — | — | 21.5 |
| Fixed income securities | ||||
| Corporate debt instruments | 98.9 | 13.9 | — | 112.8 |
| Real estate and other | ||||
| Real estate | — | — | 0.3 | 0.3 |
| Other | 0.4 | 33.9 | 5.2 | 39.5 |
| Total assets | $288.0 | $47.8 | $5.5 | $341.3 |
The following table summarizes our defined benefit pension plan assets measured at fair value as of December 31, 2023:
| Quoted Prices in Active Markets for Identical Assets · Significant Other Observable Inputs · Significant Unobservable Inputs | ||||
|---|---|---|---|---|
| (millions of dollars) | (Level 1) | (Level 2) | (Level 3) | Total |
| Equity securities | ||||
| US equities | $142.5 | $— | $— | $142.5 |
| Non-US equities | 20.4 | — | — | 20.4 |
| Fixed income securities | ||||
| Corporate debt instruments | 98.0 | 14.0 | — | 112.0 |
| Real estate and other | ||||
| Real estate | — | — | 0.8 | 0.8 |
| Other | 0.4 | 35.0 | 6.3 | 41.7 |
| Total assets | $261.3 | $49.0 | $7.1 | $317.4 |
U.S. equities – This class included actively and passively managed common equity securities comprised primarily of large-capitalization stocks with value, core and growth strategies.
Non-U.S. equities – This class included actively managed common equity securities comprised primarily of international large-capitalization stocks.
Fixed income – This class included corporate debt instruments.
Real Estate and other – This class included assets related to real estate and other assets such as insurance contracts.
Asset classified as Level 1 are valued using quoted prices on major stock exchange on which individual assets are traded. Our Level 2 assets are valued using net asset value. The net asset value is quoted on a private market that is not active; however, the unit price is based on the underlying investments that are traded on an active market. Our Level 3 assets are estimated at fair value based on the most recent financial information available for the underlying securities, which are not traded on active market, and represents significant unobservable input.
The following is a reconciliation of changes in fair value measurement of plan assets using significant unobservable inputs (Level 3):
| (millions of dollars) | |
|---|---|
| Beginning balance at December 31, 2022 | $7.6 |
| Purchases, sales, settlements | — |
| Actual (loss) return on plan assets still held at reporting date | (0.6) |
| Foreign exchange impact | 0.1 |
| Ending balance at December 31, 2023 | $7.1 |
| Purchases, sales, settlements | — |
| Actual (loss) return on plan assets still held at reporting date | (1.6) |
| Foreign exchange impact | — |
| Ending balance at December 31, 2024 | $5.5 |
There wereno transfers in or out of Level 3 during the year ended December 31, 2024 and 2023.
Contributions
The Company expects to contribute $11.0 million to its pension plans and $0.1 million to its other post-retirement benefit plan in 2025.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid:
| (millions of dollars) | Pension Benefits | Other Benefits |
|---|---|---|
| 2025 | $23.9 | $0.1 |
| 2026 | $23.9 | $0.1 |
| 2027 | $26.3 | $0.2 |
| 2028 | $25.4 | $0.2 |
| 2029 | $24.4 | $0.2 |
| 2030-2034 | $121.9 | $0.8 |
Investment Strategies
The investment strategy for pension plan assets is to maintain a broadly diversified portfolio designed to both preserve and grow plan assets to meet future plan obligations. The Company’s average rate of return on assets from inception through December 31, 2024 was approximately 9%. The Company’s assets are strategically allocated among equity, debt and other investments to achieve a diversification level that dampens fluctuations in investment returns. The Company’s long-term investment strategy is an investment portfolio mix of approximately 55%-65% in equity securities,30%-35% in fixed income securities and 0%-15% in other securities.
Savings and Investment Plan
The Company maintains a voluntary Savings and Investment Plan (a 401(k) plan) for most non-union employees in the U.S. Within prescribed limits, the Company bases its contribution to the Savings and Investment Plan on employee contributions. The Company’s contributions amounted to $6.4 million, $6.2 million and $5.7 million for the years ended December 31, 2024, 2023 and 2022, respectively.
Note 17. Contingencies
The Company is party to a number of lawsuits arising in the normal course of our business. The Company and certain of the Company’s subsidiaries are among numerous defendants in a number of cases seeking damages for alleged exposure to asbestos-contaminated talc products sold by the Company’s subsidiary BMI Oldco Inc.
On October 2, 2023 (the “Petition Date”), notwithstanding the Company’s confidence in the safety of Oldco’s talc products, the Company’s subsidiaries, Oldco and Barretts Ventures Texas LLC ("BVT" and, together with Oldco, the “Chapter 11 Debtors”), filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas (the “Chapter 11 Cases”) to address and comprehensively resolve Oldco’s liabilities associated with talc. Minerals Technologies Inc. and the Company’s other subsidiaries were not included in the Chapter 11 filing.
The Chapter 11 Debtors’ ultimate goal in the Chapter 11 Cases is to confirm a plan of reorganization under Section 524(g) of the U.S. Bankruptcy Code and utilize this provision of the Bankruptcy Code to establish a trust that will address all current and future talc-related claims. In January 2024, the Chapter 11 Debtors and Minerals Technologies Inc. commenced a court-approved mediation process with the Official Committee of Unsecured Creditors (appointed in the Chapter 11 Cases as the representative of current talc claimants) (the “Committee”) and the Future Claimants Representative (appointed in the Chapter 11 Cases as the representative of future talc claimants) regarding the terms of a potential consensual plan of reorganization and the ultimate amount to be contributed to any trust. The mediation process is ongoing.
As of December 31, 2024, we had 684 open cases related to certain talc products previously sold by Oldco, which is an increase in volume from previous years. The following table details case activity related to talc products previously sold by Oldco:
| Three Months Ended | Twelve Months Ended | |||
|---|---|---|---|---|
| (number of claims) | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2024 | Dec. 31, 2023 |
| Claims pending, beginning of period | 663 | 562 | 574 | 439 |
| Claims filed | 44 | 75 | 162 | 256 |
| Less: Claims dismissed, settled or otherwise resolved | 23 | 63 | 52 | 121 |
| Claims pending, end of period | 684 | 574 | 684 | 574 |
During the pendency of the Chapter 11 Cases, the Company anticipates that the Chapter 11 Debtors will benefit from the operation of the automatic stay, which stays ongoing litigation in connection with talc-related claims against the Chapter 11 Debtors. In addition, subject to certain exceptions, the filing or continued prosecution of all talc-related claims against the Chapter 11 Debtors’ non-debtor affiliates is temporarily stayed through April 15, 2025 (subject to further extensions), the date on which a hearing is scheduled on the status of the Chapter 11 Cases.
These claims typically allege various theories of liability, including negligence, gross negligence and strict liability and seek compensatory and, in some cases, punitive damages, but most of these claims do not provide adequate information to assess their merits, the likelihood that the Company will be found liable, or the magnitude of such liability, if any. We are unable to state an amount or range of amounts claimed in any of these lawsuits because state court pleading practices do not require the plaintiff to identify the amount of the claimed damage. The Company’s position, as stated publicly, is that the talc products sold by Oldco are safe and do not cause cancer.
The Company records accruals for loss contingencies associated with legal matters, including talc-related litigation, when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors, including whether damages sought in the proceedings are unsubstantiated or indeterminate, the stage of the litigation, the factual and legal matters in dispute, the ability to achieve comprehensive settlements, the availability of co-defendants with substantial resources and assets participating in the litigation, and our evaluation of the unique attributes of each claim.
While costs relating to the talc-related cases have increased concurrently with the volume, the majority of these costs have historically been borne by Pfizer Inc. ("Pfizer") in connection with certain agreements entered into in connection with the Company’s initial public offering in 1992, and as long as the litigation is subject to the stay under the Chapter 11 Cases (subject to certain exceptions), the Company will not be required to make any payments in respect thereof. The Company is entitled to indemnification, pursuant to agreement, for liabilities arising from sales prior to the initial public offering. On May 22, 2024, Pfizer filed a motion in the Chapter 11 Cases seeking permission to file a lawsuit against the Company related to the 1992 agreement. That motion has been adjourned, and Pfizer and the Company have agreed to mediate their disputes. The Company continues to receive information from Pfizer with respect to potential costs associated with the defense and/or settlement of talc-related cases that Pfizer alleges are not subject to indemnification. Although the Company believes that the talc products are safe and that claims to the contrary are without merit, Oldco opportunistically settled certain talc-related cases in 2022 and 2023. None of such settlements have been material to the Company.
In the second quarter of 2024, Oldco sold its talc assets under section 363 of the Bankruptcy Code. In addition, in the second quarter of 2024, the Company entered into a Debtor-in-Possession Credit Agreement with Oldco (the “DIP Credit Agreement”) and recorded a provision for credit loss of $30 million for the maximum principal amount under such Credit Agreement.
Proceeds of the sale of Oldco’s talc assets and funds drawn by Oldco under the DIP Credit Agreement will be used to fund the Chapter 11 Cases. Following the Chapter 11 filing, the activities of the Chapter 11 Debtors are now subject to review and oversight by the bankruptcy court. As a result, the Chapter 11 Debtors were deconsolidated as of the Petition Date, and their assets and liabilities were derecognized from the Company’s consolidated financial statements on a prospective basis.
On June 25, 2024, the Committee filed a motion to dismiss the Chapter 11 Cases. A hearing on the motion to dismiss, which has been adjourned several times while the parties continue to explore a consensual resolution of issues through the court-approved mediation process, is scheduled to commence on April 14, 2025 (subject to further adjournments). The Chapter 11 Cases remain pending.
The broader litigation and regulatory environments for talc-related claims continue to evolve. Moreover, although the Chapter 11 Cases are progressing, it is not possible at this time to predict how the Bankruptcy Court will rule on the pending motion to dismiss, the form of any ultimate resolution, or when an ultimate resolution might occur. Given the foregoing factors, it is reasonably possible that the Company will incur a loss for liabilities associated with future talc claims in excess of the amount currently recognized. This risk is based on the potential for new talc-related claims that could eventually be asserted together with their associated disposition cost and related legal costs, despite the automatic stay with respect to claims against the Chapter 11 Debtors, taking into account the portion of such hypothetical claims that may be subject to indemnification by Pfizer, as well as the inability to estimate the amount that may be necessary to fully and finally resolve all of the Chapter 11 Debtors’ future talc-related claims in connection with a confirmed Chapter 11 plan of reorganization. Accordingly, the Company is currently unable to provide an estimate or range of the magnitude of any potential loss related to future talc claims. While possible losses associated with future talc claims are not reasonably estimable at this time based on our current knowledge, in light of the uncertainties involved in such matters, the resolution of, or recognition of additional liabilities in connection with, current or future talc claims could have a material adverse effect on the Company’s results of operations, cash flows and financial condition.
Note 18. Stockholders’ Equity
Capital Stock
The Company’s authorized capital stock consists of 100 million shares of common stock, par value $0.10 per share, of which 31,895,655 shares and 32,404,721 shares were outstanding at December 31, 2024 and 2023, respectively, and 1,000,000 shares of preferred stock, none of which were issued and outstanding.
Cash Dividends
Cash dividends of $13.2 million or $0.41 per common share were paid during 2024. In January 2025, a cash dividend of approximately $3.5 million or $0.11 per share, was declared, payable in the first quarter of 2025.
Stock Award and Incentive Plan
The Company’s 2015 Stock Award and Incentive Plan provides for grants of incentive and non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, stock awards and performance unit awards (the 2015 Stock Award and Incentive Plan, as amended, referred to herein as the “Plan” and together with its predecessor for awards granted prior to May 2015, the 2001 Stock Award and Incentive Plan, as amended and restated, the “Plans”). At the Company's 2024 Annual Meeting of Stockholders, the Company's stockholders ratified the adoption of an amendment and restatement of the Plan, which increased the number of shares available for issuance pursuant to the Plan by 889,000 shares and removed certain individual award limits in light of recent tax law changes. The Plans are administered by the Compensation Committee of the Board of Directors. Stock options granted under the Plans generally have aten year term. The exercise price for stock options are at prices at or above the fair market value of the common stock on the date of the grant, and each award of stock options will vest ratably over a specified period, generally three years.
The following table summarizes stock option and restricted stock unit activity for the Plans:
| Stock Options · Restricted Stock Units | |||||
|---|---|---|---|---|---|
| Shares Available for Grant | Shares | Weighted Average Exercise Price per Share ($) | Shares | Weighted Average Exercise Price per Share ($) | |
| Balance January 1, 2022 | 1,268,770 | 1,330,002 | $59.91 | 196,133 | $60.87 |
| Granted | (341,187) | 242,723 | 69.81 | 98,464 | 69.70 |
| Exercised/vested | — | (121,992) | 46.81 | (52,441) | 58.92 |
| Canceled | 152,877 | (87,315) | 69.49 | (65,562) | 61.00 |
| Balance December 31, 2022 | 1,080,460 | 1,363,418 | 62.22 | 176,594 | 66.32 |
| Granted | (358,463) | 255,620 | 66.08 | 102,843 | 66.01 |
| Exercised/vested | — | (91,604) | 56.82 | (46,141) | 64.25 |
| Canceled | 58,918 | (12,972) | 67.54 | (45,946) | 64.33 |
| Balance December 31, 2023 | 780,915 | 1,514,462 | 63.15 | 187,350 | 67.15 |
| Authorized | 889,000 | — | — | — | — |
| Granted | (299,640) | 196,471 | 66.72 | 103,169 | 66.79 |
| Exercised/vested | — | (279,810) | 55.85 | (47,876) | 67.19 |
| Canceled | 49,336 | (5,487) | 66.76 | (43,849) | 67.21 |
| Balance December 31, 2024 | 1,419,611 | 1,425,636 | $65.06 | 198,794 | $66.94 |
Note 19. Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss) at December 31 comprised of the following components:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Cumulative foreign currency translation | $(399.6) | $(350.9) |
| Unrecognized pension benefit (costs) (net of tax (expense) benefit of $(1.2) in 2024 and $8.9 in 2023) | 1.9 | (28.8) |
| Unrealized gain on cash flow hedges (net of tax expense (benefit) of $0.1 in 2024 and $(1.2) in 2023) | 10.6 | 10.3 |
| $(387.1) | $(369.4) | |
The following table summarizes the changes in other comprehensive income (loss) by component:
| Year Ended December 31, | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | |||||||
| (millions of dollars) | Pre-Tax Amount | Tax (Expense) Benefit | Net-of- Tax Amount | Pre-Tax Amount | Tax (Expense) Benefit | Net-of- Tax Amount | Pre-Tax Amount | Tax (Expense) Benefit | Net-of- Tax Amount |
| Foreign currency translation adjustment | $(49.9) | $— | $(49.9) | $(6.1) | $— | $(6.1) | $(78.9) | $— | $(78.9) |
| Pension plans: | |||||||||
| Net actuarial gains (losses) and prior service costs arising during the period | 39.5 | (9.7) | 29.8 | 5.1 | (1.4) | 3.7 | 41.4 | (9.8) | 31.6 |
| Amortization of net actuarial (gains) losses and prior service costs | 1.1 | (0.3) | 0.8 | 2.5 | (0.6) | 1.9 | 4.9 | (1.2) | 3.7 |
| Unrealized gains (losses) on cash flow hedges | 0.4 | (0.1) | 0.3 | (4.5) | 1.2 | (3.3) | 10.6 | (2.8) | 7.8 |
| Total other comprehensive income (loss) | $(8.9) | $(10.1) | $(19.0) | $(3.0) | $(0.8) | $(3.8) | $(22.0) | $(13.8) | $(35.8) |
The pre-tax amortization amounts of pension plans in the table above are included within the components of net periodic pension benefit costs (see Note 16) and the related tax amounts are included within provision (benefit) for taxes on income line within Consolidated Statements of Income.
Note 20. Accounting for Asset Retirement Obligations
The Company records asset retirement obligations in which the Company will be required to retire tangible long-lived assets. These are primarily related to its PCC satellite facilities and mining operations. The Company has also recorded the provisions related to conditional asset retirement obligations at its facilities. The Company has recorded asset retirement obligations at all of its facilities except where there are no contractual or legal obligations. The associated asset retirement costs are capitalized as part of the carrying amount of the long-lived asset.
The following is a reconciliation of asset retirement obligations as of December 31, 2024 and 2023:
| December 31, | ||
|---|---|---|
| (millions of dollars) | 2024 | 2023 |
| Asset retirement obligation, beginning of period | $20.8 | $23.8 |
| Accretion expense | 1.6 | 1.1 |
| Other | 6.5 | (3.8) |
| Payments | (0.8) | (0.1) |
| Foreign currency translation | (0.5) | (0.2) |
| Asset retirement obligation, end of period | $27.6 | $20.8 |
The Company mines various minerals using a surface mining process that requires the removal of overburden. In certain areas and under various governmental regulations, the Company is obligated to restore the land comprising each mining site to its original condition at the completion of the mining activity. This liability will be adjusted to reflect the passage of time, mining activities, and changes in estimated future cash outflows.
In the third quarter of 2024, the Company recorded an additional $7.0 million of asset retirement obligations in relation to our mining business.
The current portion of the liability of approximately $0.6 million is included in other current liabilities and the long-term portion of the liability of approximately $27.0 million is included in other non-current liabilities in the Consolidated Balance Sheet as of December 31, 2024.
Accretion expense is included in cost of goods sold in the Company’s Consolidated Statements of Income.
Note 21. Segment and Related Information
The Company determines its operating segments based on the discrete financial information that is regularly evaluated by its chief operating decision maker, our Chief Executive Officer, in deciding how to allocate resources and in assessing performance. The Company’s operating segments are strategic business units that offer different products and serve different markets. They are managed separately and require different technology and marketing strategies.
The Company hastwo reportable segments: the Consumer & Specialties segment and the Engineered Solutions segment.
The Consumer & Specialties segment serves consumer end markets directly and provides mineral-based solutions and technologies that are essential to our customers’ products. Thetwo product lines in this segment are Household & Personal Care - our mineral-to-shelf product line that serves pet care, personal and household care, fluid purification and other consumer oriented markets, and Specialty Additives, delivering specialty mineral additives to a variety of consumer and industrial end markets including paper, packaging, construction, automotive, and food and pharmaceuticals.
The Engineered Solutions segment combines all engineered systems, mineral blends, and technologies that are designed to aid in customer processes and projects. Thetwo product lines in this segment are High-Temperature Technologies – combining all of our mineral-based blends, technologies, and systems serving the foundry, steel, glass, aluminum and other high-temperature processing industries, and Environmental & Infrastructure, which includes environmental and remediation solutions such as geosynthetic clay lining systems, water remediation technologies as well as drilling, commercial building and infrastructure-related products.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance based on the operating income of the respective business units. The costs deducted to arrive at operating profit do not include several items, such as net interest or income tax expense. Depreciation expense related to corporate assets is allocated to the business segments and is included in their income from operations. However, such corporate depreciable assets are not included in the segment assets. Intersegment sales and transfers are not significant.
Segment revenues, expenses, operating income and a reconciliation of the operating segment totals to the applicable line items on the consolidated financial statements is as follows:
| Year Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | |||||
| (millions of dollars) | Consumer & Specialties | Engineered Solutions | Total | Consumer & Specialties | Engineered Solutions | Total |
| Net Sales | $1,140.2 | $978.3 | $2,118.5 | $1,160.2 | $1,009.7 | $2,169.9 |
| Cost of goods sold | 890.4 | 680.4 | 1,570.8 | 938.6 | 724.4 | 1,663.0 |
| Segment production margin | 249.8 | 297.9 | 547.7 | 221.6 | 285.3 | 506.9 |
| Marketing and administrative expenses | 71.7 | 125.8 | 197.5 | 69.1 | 124.6 | 193.7 |
| Research and development expenses | 12.6 | 10.4 | 23.0 | 11.5 | 9.7 | 21.2 |
| Gain on sale of assets, net | — | (12.3) | (12.3) | — | — | — |
| Impairment of assets | — | — | — | 71.7 | — | 71.7 |
| Restructuring and other items, net | — | — | — | 0.9 | 3.2 | 4.1 |
| Litigation expenses | — | — | — | 26.8 | — | 26.8 |
| Segment income from operations | $165.5 | $174.0 | $339.5 | $41.6 | $147.8 | $189.4 |
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | Consumer & Specialties | Engineered Solutions | Total |
| Net Sales | $1,124.6 | $1,000.9 | $2,125.5 |
| Cost of goods sold | 937.0 | 723.5 | 1,660.5 |
| Segment production margin | 187.6 | 277.4 | 465.0 |
| Marketing and administrative expenses | 63.1 | 120.7 | 183.8 |
| Research and development expenses | 10.8 | 9.6 | 20.4 |
| Acquisition-related expenses | 2.1 | — | 2.1 |
| Litigation expenses | 32.6 | — | 32.6 |
| Segment income from operations | $79.0 | $147.1 | $226.1 |
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Segment income from operations | $339.5 | $189.4 | $226.1 |
| Interest expense, net | (56.4) | (59.2) | (43.9) |
| Other non-operating deductions, net | (4.7) | (4.9) | (3.8) |
| Unallocated expenses: | |||
| Provision for credit losses | 30.0 | — | — |
| Restructuring and other items, net | — | 2.8 | — |
| Acquisition-related expenses | — | 0.3 | 3.0 |
| Litigation expenses | 11.3 | 2.4 | — |
| Unallocated corporate expenses | 11.7 | 12.1 | 8.3 |
| Debt extinguishment expenses | (1.8) | — | (6.9) |
| Non-cash pension settlement charge | — | — | (3.5) |
| Income before tax and equity in earnings | $223.6 | $107.7 | $156.7 |
Segment information for the years ended December 31, 2024, 2023 and 2022 was as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Depreciation, Depletion and Amortization | |||
| Consumer & Specialties | $47.2 | $47.2 | $48.0 |
| Engineered Solutions | 47.7 | 47.7 | 46.2 |
| Total | $94.9 | $94.9 | $94.2 |
| Segment Assets | |||
| Consumer & Specialties | $1,289.4 | $1,244.8 | $1,107.5 |
| Engineered Solutions | 2,028.0 | 2,028.5 | 2,187.5 |
| Corporate | 76.5 | 73.3 | 106.6 |
| Total | $3,393.9 | $3,346.6 | $3,401.6 |
| Capital Expenditures | |||
| Consumer & Specialties | $45.2 | $56.8 | $44.3 |
| Engineered Solutions | 39.3 | 31.2 | 34.0 |
| Corporate | 5.0 | 5.5 | 4.0 |
| Total | $89.5 | $93.5 | $82.3 |
Financial information relating to the Company’s operations by geographic area was as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Net Sales | |||
| United States | $1,089.4 | $1,144.0 | $1,135.6 |
| Canada/Latin America | 151.2 | 150.2 | 148.3 |
| Europe/Africa | 521.1 | 525.5 | 496.8 |
| Asia | 356.8 | 350.2 | 344.8 |
| Total International | $1,029.1 | $1,025.9 | $989.9 |
| Consolidated net sales | $2,118.5 | $2,169.9 | $2,125.5 |
| Long-Lived Assets | |||
| United States | $1,849.1 | $1,842.0 | $1,915.8 |
| Canada/Latin America | 14.6 | 17.7 | 16.4 |
| Europe/Africa | 147.3 | 157.0 | 162.8 |
| Asia | 110.6 | 114.7 | 112.1 |
| Total International | $272.5 | $289.4 | $291.3 |
| Consolidated long-lived assets | $2,121.6 | $2,131.4 | $2,207.1 |
Net sales and long-lived assets are attributed to countries and geographic areas based on the location of the legal entity. No individual foreign country represents more than 10% of consolidated net sales or consolidated long-lived assets.
The Company’s sales by product category are as follows:
| Year Ended December 31, | |||
|---|---|---|---|
| (millions of dollars) | 2024 | 2023 | 2022 |
| Household & Personal Care | $530.0 | $517.6 | $476.2 |
| Specialty Additives | 610.2 | 642.6 | 648.4 |
| High-Temperature Technologies | 713.2 | 720.9 | 702.5 |
| Environmental & Infrastructure | 265.1 | 288.8 | 298.4 |
| Total | $2,118.5 | $2,169.9 | $2,125.5 |
Report of Independent Registered Public Accounting
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.